Citation tools
"Peptide receptor radionuclide therapy (PRRT) of treatment-refractory metastatic thyroid cancer using Yttrium-90 and Lutetium-177 labeled somatostatin analogs: Toxicity, response and survival analysis." Journal of Nuclear Medicine
51.supplement 2
(2010):
1157.
Web. 03 June. 2025.